Benutzer: Gast  Login
Mehr Felder
Einfache Suche
Titel:

A new galenic formulation of selegiline (Xilopae) in the treatment of Parkinson disease

Dokumenttyp:
Article
Autor(en):
Müller, T; Glass, J; Müller, D; Link, A; Schenk, C; Rammes, G
Abstract:
Selegiline is a selective and irreversible inhibitor of monoamine oxidase B (MAO-B). Selegiline is looked upon as a putative progression of Parkinson's disease (PD) delaying compound due to its in preclinical research proven neuroprotective modes of action. Xilopar(R) is a new formulation of selegiline, which facilitates absorption in the mouth and thus avoids hepatic first-pass metabolism. Intake of 1.25 mg Xilopar(R) provides similar pharmacokinetic plasma behaviour corresponding to oral admin...     »
Zeitschriftentitel:
Aktuelle Neurologie
Jahr:
2004
Band / Volume:
31
Heft / Issue:
7
Seitenangaben Beitrag:
347-352
Sprache:
eng
Print-ISSN:
0302-4350
TUM Einrichtung:
Klinik für Anästhesiologie (DHM)
 BibTeX